The role of FIM for weight management, including as a potential adjunctive therapy to GLP-1 use, is an area of growing interest and investigation
In the SYNERGY-NASH trial, tirzepatide showed significant rates of MASH resolution, up to 62%, compared to 10% with placebo, and improved fibrosis in over 50% of participants, said Isaacs
This dual actionboosting fullness signals and dampening hunger signalscreates a powerful appetite-suppressing effect that persists throughout the day
Tips for Effective Use Rotate Injection Sites To reduce the risk of lipodystrophy (lumps or indentations in the skin), rotate your injection sites with each dose
Medical advice should be sought before any use of retatrutide, particularly if you have: A personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) this is a precautionary consideration based on class data from GLP-1 receptor agonists
Some Hashimoto's patients, particularly those with significantly compromised thyroid function, persistent untreated insulin resistance, or cortisol dysregulation, may experience less dramatic results